Overview

RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease

Status:
Active, not recruiting
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with combination chemotherapy may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with no radiation therapy following chemotherapy in treating patients with stage III or stage IV Hodgkin's disease.
Phase:
Phase 3
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Treatments:
Bleomycin
Cobalt
Doxorubicin
Liposomal doxorubicin
Mechlorethamine
Prednisone
Procarbazine
Vinblastine
Vincristine